Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand

By Yahoo! Finance | Jun 21, 2024 at 01:11 AM EST

TimesSquare Capital Management's U.S. Small Cap Growth Strategy investor letter for Q1 2024 shows a 5.77% return, with top pick Ascendis Pharma A/S (NASDAQ:ASND) gaining. The company's operating loss decreased due to increased revenue and lower expenses.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.